{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:27:04Z","timestamp":1786670824808,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HealthTree Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01603-x","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:37:52Z","timestamp":1786667872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns and perceptions of supplement use among patients with plasma cell disorders"],"prefix":"10.1038","volume":"16","author":[{"given":"Maria A.","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Schach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Leyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-8493","authenticated-orcid":false,"given":"Andriy","family":"Derkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-5483","authenticated-orcid":false,"given":"Francesca","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4503-1690","authenticated-orcid":false,"given":"Jorge Arturo","family":"Hurtado Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-5456","authenticated-orcid":false,"given":"Ana M.","family":"Sahagun Sanchez Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-8281","authenticated-orcid":false,"given":"Patricia Alejandra","family":"Flores Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Ahlstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Hydren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-8731","authenticated-orcid":false,"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Chimonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-1091","authenticated-orcid":false,"given":"Urvi A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/JNCI\/DJAB048","volume":"114","author":"LG Balneaves","year":"2021","unstructured":"Balneaves LG, Watling CZ, Hayward EN, Ross B, Taylor-Brown J, Porcino A, et al. Addressing complementary and alternative medicine use among individuals with cancer: an integrative review and clinical practice guideline. JNCI J Natl Cancer Inst. 2021;114:25 https:\/\/doi.org\/10.1093\/JNCI\/DJAB048.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1603_CR2","first-page":"578","volume":"25","author":"RA Kyle","year":"2011","unstructured":"Kyle RA, Baudi FI, Rajkumar SV. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Oncol (Williston Park). 2011;25:578.","journal-title":"Oncol (Williston Park)"},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3322\/caac.21591","volume":"70","author":"CL Rock","year":"2020","unstructured":"Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, et al. American cancer society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70:245\u201371. https:\/\/doi.org\/10.3322\/caac.21591.","journal-title":"CA Cancer J Clin"},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/jn\/nxaa040","volume":"150","author":"M Du","year":"2020","unstructured":"Du M, Luo H, Blumberg JB, Rogers G, Chen F, Ruan M, et al. Dietary supplement use among adult cancer survivors in the United States. J Nutr. 2020;150:1499\u2013508. https:\/\/doi.org\/10.1093\/jn\/nxaa040.","journal-title":"J Nutr"},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1080\/01635581.2020.1820050","volume":"73","author":"O Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman O. Dietary supplements use among adults with cancer in the United States: a population-based study. Nutr Cancer. 2021;73:1856\u201363. https:\/\/doi.org\/10.1080\/01635581.2020.1820050.","journal-title":"Nutr Cancer"},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1200\/JCO.2014.55.8676","volume":"32","author":"RT Lee","year":"2014","unstructured":"Lee RT, Barbo A, Lopez G, Melhem-Bertrandt A, Lin H, Olopade OI, et al. National Survey of US oncologists\u2019 knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol. 2014;32:4095\u2013101. https:\/\/doi.org\/10.1200\/JCO.2014.55.8676.","journal-title":"J Clin Oncol"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1200\/JCO.19.01203","volume":"38","author":"CB Ambrosone","year":"2020","unstructured":"Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, et al. Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol. 2020;38:804\u201314. https:\/\/doi.org\/10.1200\/JCO.19.01203.","journal-title":"J Clin Oncol"},{"key":"1603_CR8","doi-asserted-by":"publisher","unstructured":"Van TTT, Chang HS, Wu HC, Lu CK, Huang HC, Korinek M, et al. The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1403424","DOI":"10.3389\/fphar.2024.1403424"},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/leu.2009.83","volume":"23","author":"G Perrone","year":"2009","unstructured":"Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G, et al. Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia. 2009;23:1679\u201386. https:\/\/doi.org\/10.1038\/leu.2009.83.","journal-title":"Leukemia"},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-022-00666-w","volume":"12","author":"MA Malik","year":"2022","unstructured":"Malik MA, Sweeney NW, Jafri M, Derkach A, Chmielewski C, Adintori PA, et al. Nutrition perceptions, needs and practices among patients with plasma cell disorders. Blood Cancer J. 2022;12:1\u20135. https:\/\/doi.org\/10.1038\/s41408-022-00666-w.","journal-title":"Blood Cancer J"},{"key":"1603_CR11","doi-asserted-by":"publisher","unstructured":"Okolo O, Wertheim BC, Larsen A, Sweeney NW, Ahlstrom JM, Gowin K Integrative Medicine in Multiple Myeloma and Plasma Cell Disorders. Complement Ther Med. 2023;73. https:\/\/doi.org\/10.1016\/j.ctim.2023.102939.","DOI":"10.1016\/j.ctim.2023.102939"},{"key":"1603_CR12","unstructured":"HealthTree Foundation [Internet]. [cited 2021 Aug 9]. HealthTree for Multiple Myeloma. https:\/\/healthtree.org\/ (2025)"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/BLOODADVANCES.2019001411","volume":"4","author":"SV Yellapragada","year":"2020","unstructured":"Yellapragada SV, Fillmore NR, Frolov A, Zhou Y, Dev P, Yameen H, et al. Vitamin D deficiency predicts for poor overall survival in white but not african american patients with multiple myeloma. Blood Adv. 2020;4:1643\u20136. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2019001411.","journal-title":"Blood Adv"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/S00432-021-03594-7","volume":"147","author":"M Tank","year":"2021","unstructured":"Tank M, Franz K, Cereda E, Norman K. Dietary Supplement Use in Ambulatory Cancer Patients: A Survey on Prevalence, Motivation and Attitudes. J Cancer Res Clin Oncol. 2021;147:1917\u201325. https:\/\/doi.org\/10.1007\/S00432-021-03594-7. PubMed PMID: 33825025.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ajh.23159","volume":"87","author":"T Golombick","year":"2012","unstructured":"Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol. 2012;87:455\u201360. https:\/\/doi.org\/10.1002\/ajh.23159.","journal-title":"Am J Hematol"},{"key":"1603_CR16","doi-asserted-by":"publisher","unstructured":"Golombick T, H. Diamond T, Manoharan A, Ramakrishna R Long-term follow-up of curcumin treated MGUS\/SMM patients \u2013 an updated single centre experience. Hematol Med Oncol. 2017;2. https:\/\/doi.org\/10.15761\/hmo.1000125","DOI":"10.15761\/hmo.1000125"},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/BLOODADVANCES.2021004958","volume":"6","author":"Y Ito","year":"2022","unstructured":"Ito Y, Honda A, Kurokawa M. Impact of Vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis. Blood Adv. 2022;6:1499\u2013511. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2021004958.","journal-title":"Blood Adv"},{"key":"1603_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctim.2004.09.006","volume":"12","author":"A Robinson","year":"2004","unstructured":"Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12:90\u20138. https:\/\/doi.org\/10.1016\/j.ctim.2004.09.006.","journal-title":"Complement Ther Med"},{"key":"1603_CR19","unstructured":"Memorial Sloan Kettering Cancer Center. About Herbs, Botanicals & Other Products | Memorial Sloan Kettering Cancer Cente. https:\/\/www.mskcc.org\/cancer-care\/diagnosis-treatment\/symptom-management\/integrative-medicine\/herbs (2026)."},{"key":"1603_CR20","unstructured":"National Center for Complementary and Integrative Health. Herbs at a Glance | NCCIH [Internet]. [cited 2026 July 2]. Available from: https:\/\/www.nccih.nih.gov\/health\/herbsataglance (2026)."},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/2159-8290.CD-25-1101","volume":"16","author":"UA Shah","year":"2026","unstructured":"Shah UA, Cogrossi LL, Garces JJ, Policastro A, Castro F, Derkach A, et al. A high-fiber plant-based diet in myeloma precursor disorders \u2013 results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model. Cancer Discov. 2026;16:697\u2013720. https:\/\/doi.org\/10.1158\/2159-8290.CD-25-1101.","journal-title":"Cancer Discov"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01603-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01603-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:37:53Z","timestamp":1786667873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01603-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01603-x","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.A.S. \u2013\n                      Sanofi:\n                      Honoraria;\n                      Bristol--Myers Squibb:\n                      Research Funding;\n                      Janssen:\n                      Honoraria, Research Funding. S.Z.U.\n                      \u2013\n                      TeneoBio:\n                      Consultancy;\n                      SkylineDX:\n                      Consultancy, Research Funding;\n                      Takeda:\n                      Consultancy, Research Funding;\n                      Sanofi:\n                      Consultancy, Research Funding;\n                      Pfizer:\n                      Consultancy; Genentech: Consultancy;\n                      Gilead:\n                      Research Funding;\n                      Amgen:\n                      Consultancy, Research Funding;\n                      Array Biopharma:\n                      Research Funding;\n                      EdoPharma:\n                      Consultancy;\n                      GSK:\n                      Consultancy, Research Funding;\n                      Merck:\n                      Research Funding;\n                      Pharmacyclics:\n                      Research Funding;\n                      Oncopeptides:\n                      Consultancy;\n                      Sanofi:\n                      Consultancy, Research Funding;\n                      SeaGen:\n                      Consultancy, Research Funding;\n                      Gracell:\n                      Consultancy;\n                      SecuraBio:\n                      Consultancy\n                      ; Abbvie:\n                      Consultancy, Research Funding;\n                      Bristol-Myers Squibb - Celgene:\n                      Consultancy, Research Funding;\n                      Johnson & Johnson - Janssen:\n                      Consultancy, Research Funding.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the MSKCC IRB and exempt from further review. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"137"}}